Drugs / Irinotecan (drug)
last change Jun 2025 re-read 3 minutes ago

Irinotecan (drug)

Developed for
colorectal cancer
Investigated by
Sun Yat-sen University

Trials 1

20262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT07150247 Jun 2025 → Jun 2027 expected colorectal cancer Sun Yat-sen University Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Irinotecan (drug) ClinicalTrials.gov intervention name — accepted as the source's own label NCT07150247 ↗